Novabay Pharmaceuticals Inc

ASE:NBY   12:58:19 PM EDT
0.63
0.00 (-0.47%)
Earnings Announcements

NovaBay Reports Q3 Loss Per Share Of $0.08

Published: 11/12/2020 21:22 GMT
NovaBay Pharmaceuticals Inc (NBY) - Novabay Pharmaceuticals Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.08.
Net Product Revenue for Q3 of 2020 Was $2.2 Million, a 34% Increase From $1.6 Million for Q3 of 2019.
Reported Cash and Cash Equivalents of $13.4 Million As of September 30, 2020.